These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34457090)

  • 1. High mRNA Expression of
    Cui Z; Xiao L; Chen F; Wang J; Lin H; Li D; Wu Z
    Dis Markers; 2021; 2021():9971799. PubMed ID: 34457090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
    Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
    Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcript levels of spindle and kinetochore-associated complex 1/3 as prognostic biomarkers correlated with immune infiltrates in hepatocellular carcinoma.
    Yu DC; Chen XY; Li X; Zhou HY; Yu DQ; Yu XL; Hu YC; Zhang RH; Zhang XB; Zhang K; An JD
    Sci Rep; 2021 May; 11(1):11165. PubMed ID: 34045512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CENPL accelerates cell proliferation, cell cycle, apoptosis, and glycolysis via the MEK1/2-ERK1/2 pathway in hepatocellular carcinoma.
    He K; Xie M; Hong W; Li Y; Yin Y; Gao X; He Y; Chen Y; You C; Li J
    Int J Biochem Cell Biol; 2024 Jan; 166():106481. PubMed ID: 37914022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
    Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
    BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TANK-Binding Kinase 1 (TBK1) Serves as a Potential Target for Hepatocellular Carcinoma by Enhancing Tumor Immune Infiltration.
    Jiang Y; Chen S; Li Q; Liang J; Lin W; Li J; Liu Z; Wen M; Cao M; Hong J
    Front Immunol; 2021; 12():612139. PubMed ID: 33679751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, immune infiltration and clinical significance of SPAG5 in hepatocellular carcinoma: A gene expression-based study.
    Chen W; Chen X; Li S; Ren B
    J Gene Med; 2020 Apr; 22(4):e3155. PubMed ID: 31860771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
    Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma.
    Zhong X; Kan A; Zhang W; Zhou J; Zhang H; Chen J; Tang S
    Aging (Albany NY); 2019 Aug; 11(15):5483-5497. PubMed ID: 31375643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
    Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
    Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Expression of Centromere Protein U Is Associated with Hepatocellular Cancer Progression.
    Yu Y; Chen X; Zhang W; Liu J
    Biomed Res Int; 2021; 2021():4051192. PubMed ID: 34957303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-Cancer and Single-Cell Analysis Reveals CENPL as a Cancer Prognosis and Immune Infiltration-Related Biomarker.
    Feng Z; Chen Y; Cai C; Tan J; Liu P; Chen Y; Shen H; Zeng S; Han Y
    Front Immunol; 2022; 13():916594. PubMed ID: 35844598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Wu M; Jiang L
    Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Spondin-2 protein expression correlates with poor prognosis in hepatocellular carcinoma.
    Feng Y; Hu Y; Mao Q; Guo Y; Liu Y; Xue W; Cheng S
    J Int Med Res; 2019 Feb; 47(2):569-579. PubMed ID: 30318967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
    Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
    Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
    Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.
    Zhang J; Song Q; Liu J; Lu L; Xu Y; Zheng W
    Dis Markers; 2019; 2019():8964015. PubMed ID: 31781310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.